Dáil Éireann Debate, Tuesday - 2 May 2017
844. Deputy Marc MacSharry asked the Minister for Health the number of applications made to the HSE for drug reimbursement since 2012; the number of these applications that were for drugs with rare disease orphan designation; and if he will make a statement on the matter. [19423/17]
Amharc ar fhreagra845. Deputy Marc MacSharry asked the Minister for Health the number of drug reimbursement applications that have been reimbursed by the HSE for all medicines since 2012 in tabular form. [19424/17]
Amharc ar fhreagra846. Deputy Marc MacSharry asked the Minister for Health the number of drug reimbursement applications that have not been recommended for reimbursement by the HSE for all medicines since 2012 in tabular form. [19425/17]
Amharc ar fhreagra847. Deputy Marc MacSharry asked the Minister for Health the number of orphan drugs that have been reimbursed by the HSE for the treatment of rare disease since 2012 in tabular form. [19426/17]
Amharc ar fhreagra848. Deputy Marc MacSharry asked the Minister for Health the number of orphan drugs that have not been recommended for reimbursement by the HSE since 2012 in tabular form; and if he will make a statement on the matter. [19427/17]
Amharc ar fhreagra849. Deputy Marc MacSharry asked the Minister for Health the details of each drug currently reimbursed since 2012 in tabular form; the date each drug was submitted for approval; the date of its subsequent commercial entry date; and if he will make a statement on the matter. [19428/17]
Amharc ar fhreagra850. Deputy Marc MacSharry asked the Minister for Health the details of each orphan drug currently reimbursed since 2012 in tabular form; the date each drug was submitted for approval; the date of its subsequent commercial entry date; and if he will make a statement on the matter. [19429/17]
Amharc ar fhreagra851. Deputy Marc MacSharry asked the Minister for Health the number of orphan drug applications which, following rapid review assessment by the National Centre for Pharmacoeconomics, NCPE, were recommended for full pharmacoeconomic assessment since 2012, in tabular form; and if he will make a statement on the matter. [19430/17]
Amharc ar fhreagra852. Deputy Marc MacSharry asked the Minister for Health the number of orphan drug applications recommended for reimbursement based solely on the NCPE’s rapid review process since 2012 in tabular form. [19431/17]
Amharc ar fhreagra853. Deputy Marc MacSharry asked the Minister for Health the number of orphan drug applications not recommended for reimbursement by the NCPE at the original submitted price that were subsequently approved for reimbursement following confidential price negotiations in tabular form; and if he will make a statement on the matter. [19432/17]
Amharc ar fhreagraI propose to take Questions Nos. 844 to 853, inclusive, together.
As this is a service matter, I have forwarded your request to the HSE who will respond to the Deputy directly.
